Key result
CRISPR-Cas systems enable specific modulation of innate immune responses and are advancing basic and translational studies of virus-host interactions.
Why the study?
Understanding and exploiting virus-host interactions is instrumental for identifying host factors involved in viral replication, developing antiviral agents, and mitigating disease severity.
CRISPR-Cas systems offer powerful tools for modulating innate immune responses and advancing basic and translational studies of virus-host interactions.
Extends CRISPR tools for virus-host research; leaves open clinical translation for immune modulation.
Viral infections cause a variety of acute and chronic human diseases, sometimes resulting in small local outbreaks, or in some cases spreading across the globe and leading to global pandemics. Understanding and exploiting virus-host interactions is instrumental for identifying host factors involved in viral replication, developing effective antiviral agents, and mitigating the severity of virus-borne infectious diseases. The diversity of CRISPR systems and CRISPR-based tools enables the specific modulation of innate immune responses and has contributed impressively to the fields of virology and immunology in a very short time. In this review, we describe the most recent advances in the use of CRISPR systems for basic and translational studies of virus-host interactions.
No takes yet. Share an insight, caveat, or question.
Brezgin et al. (2021) conducted a review in Viral infections. CRISPR-Cas systems was evaluated. CRISPR-Cas systems enable specific modulation of innate immune responses and are advancing basic and translational studies of virus-host interactions.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: